K.E. Kypreos

K.E. Kypreos

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2016 in Free Radical Research
Verified
Journal Article
Open access
Giuseppe MaulucciGiuseppe Maulucci
Giuseppe Maulucci
OCO. Cohen
O. Cohen
BDB. Daniel
B. Daniel
ASAnna Sansone
Anna Sansone
PPP. I. Petropoulou
P. I. Petropoulou
SSShlomo Sasson
Shlomo Sasson
Metabolic homeostasis of fatty acids is complex and well-regulated in all organisms. The biosynthesis of saturated fatty acids (SFA) in mammals provides substrates for β-oxidation and ATP production. Monounsaturated fatty acids (MUFA) are products of desaturases that introduce a methylene group in cis geometry in SFA. Polyunsaturated fatty acids (n-6 and n-3 PUFA) are products of elongation and desaturation of the essential linoleic acid and α-linolenic acid, respectively. The liver processes dietary fatty acids and exports them in lipoproteins for distribution and storage in peripheral tissues. The three types of fatty acids are integrated in membrane phospholipids and determine their biophysical properties and functions. This study was aimed at investigating effects of fatty acids on membrane biophysical properties under varying nutritional and pathological conditions, by integrating lipidomic analysis of membrane phospholipids with functional two-photon microscopy (fTPM) of cellular membranes. This approach was applied to two case studies: first, pancreatic beta-cells, to investigate hormetic and detrimental effects of lipids. Second, red blood cells extracted from a genetic mouse model defective in lipoproteins, to understand the role of lipids in hepatic diseases and metabolic syndrome and their effect on circulating cells.

1 January 2010 in Atherosclerosis
Verified
Journal Article
Closed access
ETEirini M. Tsompanidi
Eirini M. Tsompanidi
MBMaria S. Brinkmeier
Maria S. Brinkmeier
EFElisavet H. Fotiadou
Elisavet H. Fotiadou
SGSmaragda M. Giakoumi
Smaragda M. Giakoumi
KKK.E. Kypreos
K.E. Kypreos

1 February 2013 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
ITI.-E. Triantaphyllidou
I.-E. Triantaphyllidou
EKE. Kalyvioti
E. Kalyvioti
EKE. Karavia
E. Karavia
ILI. Lilis
I. Lilis
KKK.E. Kypreos
K.E. Kypreos
Dionysios J. PapachristouDionysios J. Papachristou
Dionysios J. Papachristou

1 May 2017 in Journal of Endocrinology
Verified
Journal Article
Closed access
PDF file
NPNicholaos I Papachristou
Nicholaos I Papachristou
HBHarry C Blair
Harry C Blair
KKK.E. Kypreos
K.E. Kypreos
Dionysios J. PapachristouDionysios J. Papachristou
Dionysios J. Papachristou
It is well appreciated that high-density lipoprotein (HDL) and bone physiology and pathology are tightly linked. Studies, primarily in mouse models, have shown that dysfunctional and/or disturbed HDL can affect bone mass through many different ways. Specifically, reduced HDL levels have been associated with the development of an inflammatory microenvironment that affects the differentiation and function of osteoblasts. In addition, perturbation in metabolic pathways of HDL favors adipoblastic differentiation and restrains osteoblastic differentiation through, among others, the modification of specific bone-related chemokines and signaling cascades. Increased bone marrow adiposity also deteriorates bone osteoblastic function and thus bone synthesis, leading to reduced bone mass. In this review, we present the current knowledge and the future directions with regard to the HDL–bone mass connection. Unraveling the molecular phenomena that underline this connection will promote the deeper understanding of the pathophysiology of bone-related pathologies, such as osteoporosis or bone metastasis, and pave the way toward the development of novel and more effective therapies against these conditions.

13 July 2021 in Diabetologia
Verified
Journal Article
Closed access
PDF file
EXEva Xepapadaki
Eva Xepapadaki
INIoanna Nikdima
Ioanna Nikdima
ESEleftheria C. Sagiadinou
Eleftheria C. Sagiadinou
EZEvangelia Zvintzou
Evangelia Zvintzou
KKK.E. Kypreos
K.E. Kypreos

26 March 2007 in Biochemical Journal
Verified
Journal Article
Closed access
KKK.E. Kypreos
K.E. Kypreos
VZVassilis I. Zannis
Vassilis I. Zannis
We have investigated the ability of apoE (apolipoprotein E) to participate in the biogenesis of HDL (high-density lipoprotein) particles in vivo using adenovirus-mediated gene transfer in apoA-I−/− (apolipoprotein A-I) or ABCA1−/− (ATP-binding cassette A1) mice. Infection of apoA-I−/− mice with 2×109 pfu (plaque-forming units) of an apoE4-expressing adenovirus increased both HDL and the triacylglycerol-rich VLDL (very-low-density lipoprotein)/IDL (intermediate-density lipoprotein)/LDL (low-density lipoprotein) fraction and generated discoidal HDL particles. ABCA1−/− mice treated similarly failed to form HDL particles, suggesting that ABCA1 is essential for the generation of apoE-containing HDL. Combined infection of apoA-I−/− mice with a mixture of adenoviruses expressing both apoE4 (2×109 pfu) and human LCAT (lecithin:cholesterol acyltransferase) (5×108 pfu) cleared the triacylglycerol-rich lipoproteins, increased HDL and converted the discoidal HDL into spherical HDL. Similarly, co-infection of apoE−/− mice with apoE4 and human LCAT corrected the hypercholesterolaemia and generated spherical particles, suggesting that LCAT is essential for the maturation of apoE-containing HDL. Overall, the findings indicate that apoE has a dual functionality. In addition to its documented functions in the clearance of triacylglycerol-rich lipoproteins, it participates in the biogenesis of HDL-sized apoE-containing particles. HDL particles generated by this pathway may account at least for some of the atheroprotective functions of apoE.